Functional analysis of the env open reading frame in human endogenous retrovirus IDDMMK1,222 encoding superantigen activity

Journal of Virology

Volumn 74, Issue 14, 2000, Pages 6386-6393

  Lapatschek, Matthias ^a   Dürr, Susanne ^a   Löwer, Roswitha ^b   Magin, Christine ^b   Wagner, Hermann ^a   Miethke, Thomas ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIGEN RECOGNITION; ARTICLE; B CELL LYMPHOMA; GENE AMPLIFICATION; MOLECULAR CLONING; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; RETROVIRUS; T LYMPHOCYTE;

ANIMALS; BASE SEQUENCE; CELL LINE; CLONING, MOLECULAR; ENDOGENOUS RETROVIRUSES; GENE PRODUCTS, ENV; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPERANTIGENS; T-LYMPHOCYTES; TRANSFECTION;

EID: 0343517094     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.14.6386-6393.2000     Document Type: Article

References (30)

1. Acha-Orbea, H. 1992. Retroviral superantigens. Chem. Immunol. 55:65-86.
2. Acha-Orbea, H., and E. Palmer. 1991. Mls - a retrovirus exploits the immune system. Immunol. Today 12:355-361.
3. Acha-Orbea, H., A. N. Shakov, L. Scarpellino, E. Kolb, V. Müller, A. Vessaz-Shaw, R. Fuchs, K. Blöchlinger, P. Rollini, J. Billotte, M. Sarafidou, H. R. MacDonald, and H. Diggelmann. 1991. Clonal deletion of Vß14-bearing T cells in mice transgenic for mammary tumour virus. Nature 350:207-211.
4. Akolkar, P. N., B. Gulwani-Akolkar, R. Pergolizzi, K. D. Bigler, and J. Silver. 1993. Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J. Immunol. 150:2761-2773.
5. Boller, K., O. Janssen, H. Schuldes, R. R. Tönjes, and R. Kurth. 1997. Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J. Virol. 71:4581-4588.
6. Boller, K., H. Konig, M. Sauter, N. Mueller Lantzsch, R. Lower, J. Lower, and R. Kurth. 1993. Evidence that HERV-K is the endogenous retrovirus sequence that codes for the human teratocarcinoma-derived retrovirus HTDV. Virology 196:349-353.
7. Brocke, S., A. Gaur, C. Piercy, A. Gautam, K. Gijbels, C. G. Fathman, and L. Steinman. 1993. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature 365:642-644.
8. Clark, S. P., B. Arden, D. Kabelitz, and T. W. Mak. 1995 Comparison of human and mouse T-cell receptor variable gene segment subfamilies. Immunogenetics 42:531-540.
9. Conrad, B., E. Weidmann, G. Trucco, W. A. Rudert, R. Behboo, C. Ricordi, H. Rodriquez-Rilo, D. Finegold, and M. Trucco. 1994. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 371:351-355.
10. Conrad, B., R. N. Weissmahr, J. Boni, R. Arcari, J. Schupbach, and B. Mach. 1997. A human endogenous retroviral superantigen as candidate autoimmune gene in type 1 diabetes. Cell 90:303-313.
11. Dellabona, P., J. Peccoud, J. Kappler, P. Marrack, C. Benoist, and D. Mathis. 1990. Superantigens interact with MHC class II molecules outside of the antigen groove. Cell 62:1115-1121.
12. Fraser, J. D. 1989. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature 339:221-223.
13. Golzinger, N., M. Sauter, K. Roemer, and N. Mueller-Lantzsch. 1996. Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours. J. Gen. Virol. 77:2983-2990.
14. Gunzburg, W. H., F. Heinemann, S. Wintersperger, T. Miethke, H. Wagner, V. Erfle, and B. Salmons. 1993. Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat. Nature 364:154-158.
15. Herman, A., J. W. Kappler, P. Marrack, and A. M. Pullen. 1991. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745-772.
16. Kim, K. J., C. Kanellupoulos-Langevin, R. M. Merwin, D. H. Sachs, and R. Asofsky. 1979. Establishment and characterization of BALB/c lymphoma lines with B cell properties. J. Immunol. 122:549-554.
17. Labrecque, N., H. McGrath, M. Subramanyam, B. T. Huber, and R. P. Sekaly. 1993. Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features. J. Exp. Med. 177:1735-1743.
18. Lan, M. S., A. Mason, R. Coutant, Q. Y. Chen, A. Vargas, J. Rao, R. Gomez, S. Chalew, R. Garry, and N. K. Maclaren. 1998. HERV-K10s and immunemediated (type 1) diabetes. Cell 95:14-16.
19. Lower, R., K. Boller, B. Hasenmaier, C. Korbmacher, N. Muller-Lantzsch, J. Lower, and R. Kurth. 1993. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc. Natl. Acad. Sci. USA 90:4480-4484.
20. Lower, R., R. R. Tonjes, K. Boller, J. Denner, B. Kaiser, R. C. Phelps, J. Lower, R. Kurth, K. Badenhoop, H. Donner, K. H. Usadel, T. Miethke, M. Lapatschek, and H. Wagner. 1998. Development of insulin-dependent diabetes mellitus does not depend on specific expression of the human endogenous retrovirus HERV-K. Cell 95:11-14.
21. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705-711.
22. Murphy, V. J., L. C. Harrison, W. A. Rudert, P. Luppi, M. Trucco, A. Fierabracci, P. A. Biro, and G. F. Bottazzo. 1998. Retroviral superantigens and type 1 diabetes mellitus. Cell 95:9-11.
23. Perron, H., J. A. Garson, F. Bedin, F. Beseme, G. Paranhos-Baccala, F. Komurian-Pradel, F. Mallet, P. W. Tuke, C. Voisset, J. L. Blond, B. Lalande, J. M. Seigneurin, B. Mandrand, and The Collaborative Research Group on Multiple Sclerosis. 1997. Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 94:7583-7588.
24. Schommer, S., M. Sauter, H. G. Krausslich, B. Best, and N. Mueller-Lantzsch. 1996. Characterization of the human endogenous retrovirus K proteinase. J. Gen. Virol. 77:375-379.
25. Subramanyam, M., B. McLellan, N. Labrecque, R. P. Sekaly, and B. T. Huber. 1993. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells. J. Immunol. 151:2538-2545.
26. Tonjes, R. R., K. Boller, C. Limbach, R. Lugert, and R. Kurth. 1997. Characterization of human endogenous retrovirus type K virus-like particles gencrated from recombinant baculoviruses. Virology 233:280-291.
27. Tönjes, R. R., C. Limbach, R. Löwer, and R. Kurth. 1997. Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells. J. Virol. 71:2747-2756.
28. Tonjes, R. R., R. Lower, K. Boller, J. Denner, B. Hasenmaier, H. Kirsch, H. Konig, C. Korbmacher, C. Limbach, R. Lugert, R. C. Phelps, J. Scherer, K. Thelen, J. Lower, and R. Kurth. 1996. HERV-K: the biologically most active human endogenous retrovirus family. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13(Suppl. 1):S261-S261
29. Vogetseder, W., A. Dumfahrt, P. Mayersbach, D. Schonilzer, and M. P. Dierich. 1993. Antibodies in human sera recognizing a recombinant outer membrane protein encoded by the envelope gene of the human endogenous retrovirus K. AIDS Res. Hum. Retrov. 9:687-694.
30. Wintersperger, S., S. Indraccolo, T. Miethke, W. H. Gunzburg, and B. Salmons. 1994. A transient assay for gene expression studies in B lymphocytes and its use for superantigen assays. BioTechniques 16:882-886.